ARCHIVES

Cephalon To Plead Guilty, Pay $425M For Off-Label Marketing.

This article is from The Cancer Letter archive.

Vol. 34 No. 36 | October 3, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: Breast Cancer Stamp Unveiled; Payne Moves To MSK; Survivor To Bike Across U.S.

July 31, 1998

President’s Cancer Panel Seeks Ways to Open Grants For More New Ideas

December 19, 1980

In Brief: Sondik is Acting NCI Deputy Director; $21 mil. Gift Supports Univ. Of Chicago

March 4, 1994

EntreMed Begins Phase I/II Trial For Endostatin.

July 27, 2001

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006

Senators Urge Grassroots Support For Health Research Fund Legislation

May 16, 1997